文献速递慢阻肺肺栓塞与肺血管病

小叶前动脉扩张介导COPDGene研究中定量间质异常对结局的影响

Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

在COPDGene队列8200名曾吸烟者中,定量间质异常(QIA)负担与血管损伤指标(包括小叶前动脉扩张)正相关。

要点

  • QIA负担与小叶前动脉扩张等血管损伤指标正相关
  • 小叶前动脉扩张介导QIA对6分钟步行距离影响的79.6%
  • 小叶前动脉扩张或为QIA中肺血管病变的新标志物

核心结论

  • 肺实质QIA主要通过肺血管病变对结局产生不利影响。
  • 小叶前动脉扩张可能是QIA中肺血管病变的新标志物。

研究设计与样本

  • 从COPDGene队列中选取有QIA、结局数据和肺血管中介数据的曾吸烟者。
  • 采用调整的因果中介分析确定肺血管是否介导QIA对结局的影响。
  • 共纳入8200名参与者。

主要发现

  • QIA负担与小叶前动脉扩张等血管损伤指标正相关。
  • 肺动脉与主动脉比值是弱中介,右心室与左心室比值是抑制因素。
  • QIA与改良mMRC呼吸困难评分≥2的关系中观察到类似结果。
  • 小叶前动脉扩张与血管生成素-2和N末端脑钠肽前体等肺血管功能障碍生物标志物水平升高相关。

临床怎么用

  • 在QIA患者中应关注肺血管病变,尤其是小叶前动脉扩张。
  • 小叶前动脉扩张可作为QIA相关肺血管病变的潜在影像标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Quantitative interstitial abnormalities (QIAs) are a computed tomography (CT) measure of early parenchymal lung disease associated with worse clinical outcomes, including exercise capacity and symptoms. The presence of pulmonary vasculopathy in QIAs and its role in the QIA-outcome relationship is unknown. Objectives: To quantify radiographic pulmonary vasculopathy in QIAs and determine whether this vasculopathy mediates the QIA-outcome relationship. Methods: Ever-smokers with QIAs, outcomes, and pulmonary vascular mediator data were identified from the Genetic Epidemiology of COPD (COPDGene) study cohort. CT-based vascular mediators were right ventricle-to-left ventricle ratio, pulmonary artery-to-aorta ratio, and preacinar intraparenchymal arterial dilation (pulmonary artery volume, 5-20 mm2 in cross-sectional area, normalized to total arterial volume). Outcomes were 6-minute walk distance and a modified Medical Council Research Council Dyspnea Scale score of 2 or higher. Adjusted causal mediation analyses were used to determine whether the pulmonary vasculature mediated the QIA effect on outcomes. Associations of preacinar arterial dilation with select plasma biomarkers of pulmonary vascular dysfunction were examined. Measurements and Main Results: Among 8,200 participants, QIA burden correlated positively with vascular damage measures, including preacinar arterial dilation. Preacinar arterial dilation mediated 79.6% of the detrimental impact of QIA on 6-minute walk distance (56.2-100%; P < 0.001). Pulmonary artery-to-aorta ratio was a weak mediator, and right ventricle-to-left ventricle ratio was a suppressor. Similar results were observed in the relationship between QIA and modified Medical Council Research Council dyspnea score. Preacinar arterial dilation correlated with increased pulmonary vascular dysfunction biomarker levels, including angiopoietin-2 and N-terminal brain natriuretic peptide. Conclusions: Parenchymal QIAs deleteriously impact outcomes primarily through pulmonary vasculopathy. Preacinar arterial dilation may be a novel marker of pulmonary vasculopathy in QIAs.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Harder EM, Nardelli P, Pistenmaa CL, et al. Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study. Am J Respir Crit Care Med. 2024. PMID: 38820122. doi:10.1164/rccm.202312-2342OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。